Brighton Jones LLC
CORT icon

Brighton Jones LLC’s Corcept Therapeutics CORT Stock Holding History

Brighton Jones LLC’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.31M Buy
11,335
+3,872
+52% +$416K 0.02% 426
2026
Q2 		$649K Buy
+7,463
New +$451K 0.01% 687
2025
Q4 		– Sell
-3,483
Closed -$289K – 226
2025
Q3 		$289K Buy
+3,483
New +$252K 0.01% 826

Other funds holding CORT

Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.9B AUM 30.31% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Brown Capital Management
Brown Capital Management Baltimore, Maryland $527M AUM 33.67% 1-Year Est. Return

Brighton Jones LLC's CORT Position: Q3 2026 in Review

Brighton Jones LLC increased its Corcept Therapeutics (CORT) stake by 52% in Q3 2026, buying an estimated $416K and bringing the position to 11,335 shares worth $1.31M. The position accounts for 0.02% of the portfolio, ranked #426.

Brighton Jones LLC first reported a position in CORT in Q3 2025 and has held it in 3 quarters since. 178 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Brighton Jones LLC held 11,335 shares of Corcept Therapeutics worth $1.31M as of Q3 2026.
  • Brighton Jones LLC bought 3,872 Corcept Therapeutics shares in Q3 2026, an estimated $416K.
  • Corcept Therapeutics made up 0.02% of Brighton Jones LLC's portfolio in Q3 2026, its #426 holding.
  • Brighton Jones LLC first reported a position in Corcept Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 178 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Brighton Jones LLC's 13F filing for Q3 2026, filed 3 Nov 2026.